Cullinan Oncology Llc Stock Widgets and Gadgets
| CGEM Stock | USD 13.09 0.32 2.51% |
| Intraday Equity Chart Quick Equity Feed Equity Search Quote Ticker Widgets Data Sheet |
Live Stock Ticker Example
- CGEM Cullinan Oncology LLC
- CGEM 13.09 0.32
- Low 12.43
- High 13.11
- Alpha -0.5
- Beta -0.66
- Return On Equity -0.27
- Return On Asset -0.2
- Current Valuation 186.57 M
- Shares Outstanding 58.23 M
- Shares Owned By Insiders 4.49 %
- Shares Owned By Institutions 95.51 %
- Number Of Shares Shorted 8.71 M
- Price To Earning 5.23 X
- Price To Book 1.21 X
- Price To Sales 26.88 X
- Gross Profit 18.94 M
- EBITDA (190.34 M)
- Net Income (153.16 M)
- Cash And Equivalents 611 M
- Cash Per Share 13.40 X
- Total Debt 3.59 M
- Debt To Equity 0 %
- Current Ratio 10.04 X
- Book Value Per Share 10.80 X
- Cash Flow From Operations (134.28 M)
- Short Ratio 18.00 X
- Earnings Per Share (2.84) X
- Target Price 33.0
- Number Of Employees 85
- Beta -0.12
- Market Capitalization 762.2 M
- Total Asset 484.18 M
- Retained Earnings (200.86 M)
- Working Capital 452.05 M
- Net Asset 484.18 M
- Accumulation Distribution 0.0519
- Daily Balance Of Power 0.4706
- Rate Of Daily Change 1.03
- Day Median Price 12.77
- Day Typical Price 12.88
- Market Facilitation Index 0.68
- Price Action Indicator 0.48
- Period Momentum Indicator 0.32
- Relative Strength Index 38.89
Market Snapshot Widget Example
DAX Index Germany | 19,426 0.85 | |
Taiwan Weighted Taiwan | 22,299 0.16 | |
PSI 20 Stock Portugal | 6,431 0.20 | |
CROBEX Croatia | 3,159 0.26 | |
Budapest SE Hungary | 78,374 0.83 | |
IDX 30 Jakarta Indonesia | 447.75 0.92 | |
ISEQ 20 Price Ireland | 1,594 0.58 | |
NYSE Comp USA | 20,210 0.05 | |
Tel Aviv 35 Israel | 2,260 0.72 | |
Coreshares Index Tracker South Afric | 1,106 1.00 | |
IPC MEXICO Mexico | 49,861 0.05 | |
KL Technology Malaysia | 58.73 1.56 | |
IBEX 35 Index Spain | 11,611 0.27 | |
SP Merval Argentina | 1,000,000 0.00 | |
Austrian Traded Index Austria | 3,529 0.63 | |
SPASX Dividend Opportunities Australia | 1,696 0.33 | |
HNX 30 Vietnam | 474.27 0.32 | |
Bucharest BET-NG Romania | 1,209 0.20 | |
AMS Small Cap Netherlands | 1,215 3.41 | |
Oslo Exchange Mutual Norway | 1,413 0.06 | |
BEL Small Belgium | 8,045 0.09 | |
Basic Materials Brazil | 5,771 0.17 | |
Swiss Leader Price Switzerland | 1,929 0.49 | |
Fondo Mutuo ETF Chile | 1,362 0.28 | |
Athens General Comp Greece | 1,404 0.01 | |
Stock Exchange Of Thailand | 1,428 0.17 | |
PX Prague Stock Czech Repub | 1,689 0.35 | |
THE PHILIPPINE STOCK Philippines | 6,639 0.96 | |
WIG 30 Poland | 2,801 0.2 | |
BIST Electricity Turkey | 489.17 0.36 |
Investing Ideas
In addition to having Cullinan Oncology in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Thematic Opportunities
Explore Investment Opportunities
Compare Cullinan Oncology
Compare Cullinan Oncology To Peers
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cullinan Oncology LLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as various price indices. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Is Pharmaceutical Products space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cullinan Oncology. If investors know Cullinan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cullinan Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Cullinan Oncology LLC is measured differently than its book value, which is the value of Cullinan that is recorded on the company's balance sheet. Investors also form their own opinion of Cullinan Oncology's value that differs from its market value or its book value, called intrinsic value, which is Cullinan Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cullinan Oncology's market value can be influenced by many factors that don't directly affect Cullinan Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cullinan Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cullinan Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cullinan Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.